Company News

Valeant Picks Up PreCision Dermatology

Author Image

By: TOM BRANNA

Editor

Valeant Pharmaceuticals has entered into an agreement to acquire PreCision Dermatology, Inc. for $475 million in cash, plus an additional $25 million payable upon the achievement of a sales-based milestone. PreCision develops and markets dermatology products such as Locoid, Hylatopic, Clindagel and BenzEFoam.  “PreCision Dermatology has a wide range of medical dermatology products, treating a number of topical disease states such as acne and atopic dermatitis, and should bring tremendous value ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters